still hungry on semaglutide Why Am I Semaglutide? What No One Tells You Has anyone else noticed increased
Description
NovoLog comes as a solution thats given as a subcutaneous injection
However, while GLP-1 receptor agonists may eventually play a role perhaps even a significant one in the specialty, more information is needed to more concretely determine its benefits
On the other hand, there are also some real significant and potentially dangerous side effects that surfaced in clinical trials
There is no one-size-fits-all solution, and individual experiences vary widely
Patients should be advised that GLP-1 receptor agonists are not insulin, but some patients may need both a GLP-1 receptor agonist and insulin
